AzTrials
AzTrials

MyopiaNCT02962544

Comparison Between FS- LASIK and FS-SMILE for Correction of Myopia and Myopic Astigmatism

A study testing FS-SMILE, FS- LASIK and Visumax device in people with Myopia, run by Kasr El Aini Hospital at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Aim of the work is to compare the results of femtosecond assisted LASIK and small incision lenticule extraction (SMILE) as regards safety, efficacy and predictability. As a secondary outcomes , the investigators will compare the results of both techniques on corneal biomechanics, dry eye measures, corneal asphericity… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Myopia
What is being tested?
FS-SMILE, FS- LASIK and Visumax device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteEgypt
Study dates
Mar 2015to Feb 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age is 18 years or older.
  • Best corrected visual acuity of 6/6.
  • Manifest refraction spherical equivalent (MRSE) not more than 9diopters (D).
  • Refractive cylinder not more than 3 diopters (D).
  • No topographic evidence of forme frust keratoconus (FFKC).
  • No progressive change of sphere or cylinder more than 0.5 diopter per year.

Who cannot join

  • Previous history of ocular trauma or ocular surgery.
  • Concomitant active or previous ocular disease such as uveitis and glaucoma.
  • Systemic diseases affecting wound healing such as diabetes mellitus, collagen vascular diseases
  • Dry eye.

Trial locations and contacts

1 site in 1 country.

Esraa MA El-Mayah, Msc contact

(002)01002208106

e_mayah87@yahoo.com

esraa MA El-Mayah, MSC contact

(002)010002208106

E_MAYAH87@YAHOO.COM

Egypt1 site, 1 recruiting
  • Kasr Alainy Hospital

    Cairo, 11956

    Esraa MA EL-Mayah, MSC, (002)01002208106, E_MAYAH87@YAHOO.COM

    Mohsen N Salem, MD

    Recruiting

Other trials in Egypt

About this study

Official title: Comparison Between Femtosecond Assisted LASIK and Small Incision Lenticule Extraction (SMILE) for Correction of Myopia and Myopic Astigmatism

Aim of the work is to compare the results of femtosecond assisted LASIK and small incision lenticule extraction (SMILE) as regards safety, efficacy and predictability. As a secondary outcomes , the investigators will compare the results of both techniques on corneal biomechanics, dry eye measures, corneal asphericity and higher order aberration.

Read the detailed description

Rationale and Background

LASIK (laser in situ keratomileusis) is a surgical procedure designed to correct refractive errors. LASIK involves creating a corneal flap using a microkeratome followed by reshaping the cornea using an excimer laser to remove tissue from the underlying stromal bed and then replacing the corneal flap.

LASIK evolved from a variety of techniques in refractive surgery. Keratomileusis, with both freeze and non-freeze techniques was used in the USA in the 1970s.This procedure was followed by automated lamellar keratoplasty (ALK), in which a microkeratome was used to create either a free cap or a hinged corneal flap. Tissue from the corneal bed was removed to alter the refractive error and the flap was replaced. Keratomileusis and ALK were relatively imprecise mechanical techniques. After the ophthalmic excimer laser has been developed, it has been used to reshape the cornea in a technique called photorefractive keratectomy (PRK). LASIK combines the technique of creating a hinged corneal flap from ALK with excimer laser ablation from PRK. Potential advantages of LASIK over PRK include earlier postoperative stabilization and faster improvement of visual acuity, less postoperative patient discomfort, shorter duration of postoperative medication use and an easier enhancement procedure.

However LASIK -like any other surgical procedures- is not without complications. Complications of LASIK include dry eye, glare and night vision complaints and the most serious flap complications which include button hole, free cap, incomplete flap, infection and inflammation.

Femtosecond lasers have been widely used in LASIK to fashion a corneal flap instead of mechanical microkeratome, which is followed by corneal ablation using excimer laser. The advantages of femotosecond or 'bladeless' LASIK over microkeratome LASIK flaps are more precise flap thickness, reduced postoperative dry eye symptoms, reduced flap dislocation and reduced incidence of buttonholes or free caps.

Recently, refractive lenticule extraction (ReLEx) has been introduced as a single laser refractive procedure (all-in-one femtosecond LASIK) without the use of an excimer laser. Small incision lenticule extraction (SMILE) is a variation of ReLEx which requires no retractable flap so reducing the incidence of flap complications, dry eye, reducing the surgical time and patient discomfort through operating on only one device in addition to decreasing the risk of ectasia.

Patients and methods Type of study Our study is a prospective, non-randomized, comparative clinical study applied on patients with myopia or myopic astigmatism.

Treatment group The study will include 60 eyes of patients with myopia or myopic astigmatism presenting for refractive correction. Femtosecond assisted LASIK group will include 30 eyes and SMILE group will include 30 eyes.

Pre-operative examination

All patients will undergo complete ophthalmological examination before surgery, including:

  • Uncorrected and best corrected visual acuity assessement using snellen visual acuity chart.
  • Manifest refraction.
  • Slit lamp examination.
  • IOP measurement.
  • Dilated fundus examination
  • Assessment for dry eye using Schirmer test and tear break up time test (TBUT).
  • Corneal topographic analysis using combined Schimpflug and placido disc imaging principles using CSO topography system (CSO, Firenze, Italy).
  • Wavefront analysis.
  • Corneal biomechanical parameters using Ocular Response Analyzer (ORA; Reichert Inc, Depew, NY).

Surgical procedure LASIK procedure Each LASIK procedure will be performed using a standard, established technique. Under topical anesthesia and standard draping, a lid speculum is used to retract the eyelids. A superiorly hinged 100 μm thick flap will be created using the WaveLight FS200 (Alcon Laboratories, Inc.) With inverted side cut (115 ̊) .Excimer laser ablation is then performed using WaveLight EX500 excimer laser (Alcon Laboratories, Inc.).After ablation, the flap will be carefully repositioned, and postoperative medications are commenced.

SMILE procedure Each SMILE procedure will be performed using an established, described technique. After application of topical anesthesia, standard sterile draping, and insertion of the speculum, the patient's eye will be centered and docked with the curved interface cone before application of suction fixation.

The laser will be activated for photo-dissection in the following sequence: first the posterior surface of the refractive lenticule (spiral in), then the lenticule border is created. The anterior surface of the refractive lenticule (spiral out) is then formed which extended beyond the posterior lenticule diameter by 0.5 mm to form the anterior flap and is followed by a rim cut.

After the suction is released, a Siebel spatula (Rhein Medical, Heidelberg, Germany) is inserted under the cap near the hinge before the cap is separated. The edge of the refractive lenticule is separated from the stromal bed with a sinsky hook and the posterior border of the lenticule gently separated with the Siebel spatula. The lenticule is then grasped with non-toothed serrated forceps through the small incision.

Postoperative management

Postoperative treatment:

  • Topical tobramycin and dexamethasone eye drops (Tobradex; Alcon Laboratories, Inc., Fort Worth, TX) was used postoperatively every 6 hours for 1 week and stopped.
  • Topical lubricants was also prescribed to be applied every 6 hours for 1 month (refresh liquigel, Allergan Laboratories, Inc.).

Postoperative assessment:

  • Postoperative visits were scheduled for the first postoperative day, 1 month and 3 months after surgery. On the first postoperative day, UCVA measurement and slit-lamp examination (flap position and corneal integrity) will be performed. Three months after surgery, the same clinical examinations as preoperatively was performed.

Statistical analysis Data will be presented in terms of parametric and non-parametric data. Parametric data will be analyzed with paired student t test. Non-parametric data will be analyzed with Wilcoxon test. Statistical significance will be considered at 95% confidence interval. All tests will be two tailed and considered significant at p < 0.05 and highly significant at p < 0.01.

Conditions
Myopia
Being tested
FS-SMILE, FS- LASIK, Visumax device, FS 200 device
Keywords
Femtosecond, Small incision lenticule extraction, Lenticule extraction, LASIK, Myopia
Medical subject headings
Myopia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • FS-SMILEProcedure or surgery

    The procedure will be performed using an established technique. the patient's eye will be centered and docked with the curved interface cone before application of suction fixation.The laser will be activated for photo-dissection in the following sequence: first the posterior surface of the refractive lenticule then the lenticule border then The anterior surface of the refractive lenticule which extended beyond the posterior lenticule diameter by 0.5 mm to form the anterior flap and is followed by a rim cut. After the suction is released, a Siebel spatula is inserted under the cap near the hinge before the cap is separated. The edge of the refractive lenticule is separated from the stromal bed with a sinsky hook and the posterior border of the lenticule gently separated with the Siebel spatula. The lenticule is then grasped with forceps through the small incision.

  • FS- LASIKProcedure or surgery

    LASIK procedure Each LASIK procedure will be performed using a standard, established technique. Under topical anesthesia and standard draping, a lid speculum is used to retract the eyelids. A superiorly hinged 100 μm thick flap will be created using the WaveLight FS200 (Alcon Laboratories, Inc.) With inverted side cut (115 ̊) .Excimer laser ablation is then performed using WaveLight EX500 excimer laser (Alcon Laboratories, Inc.).After ablation, the flap will be carefully repositioned, and postoperative medications are commenced.

  • Visumax deviceDevice

  • FS 200 deviceDevice

Study groups in NCT02962544
Study groupRoleWhat they receive
Visumax device for FS-SMILE groupActive comparator(FS-SMILE )femtosecond small incision lenticule extraction procedure using Visumax laser device as a surgical intervention for correction of myopia and myopic astigmatism will be done for 30 eyes of patients with myopia or myopic astigmatism.
Receives: Procedure: FS-SMILE; Device: Visumax device
FS 200 device for FS-LASIK groupActive comparator(FS-LASIK)femtosecond assisted LASIK procedure using Fs200 laser device as a surgical intervention for correction of myopia and myopic astigmatism will be done for 30 eyes of patients with myopia or myopic astigmatism.
Receives: Procedure: FS- LASIK; Device: FS 200 device

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. refractive predictability(manifest refraction spherical equivalent using autorefractometer)

    • Refractive predictability, which is defined as the proportion number of eyes achieving a postoperative spherical equivalent (SE) within ±0.50 D of the intended target.

    Measured: change from baseline at 3 months postoperative.

  2. efficacy(Unaided distance visual acuity using snellen chart)

    Efficacy: defined as the proportion number of eyes achieving an unaided visual acuity (UDVA) of 20/20 or better postoperatively (efficacy= postoperative UCVA/preoperative BCVA %).

    Measured: change from baseline at 3 months postoperative.

  3. safety( Corrected distance visual acuity using snellen chart)

    Safety: defined as the proportion number of eyes that lost or gained one or more lines of postoperative best corrected visual acuity (BCVA) relative to the preoperative BCVA (Safety= Postoperative BCVA/preoperative BCVA %)

    Measured: change from baseline at 3 months postoperative.

Secondary outcomes (5)
  1. corneal hysteresis

    corneal hysteresis will be measured by ORA device and the investigators will compare between the preoperative and postoperative results in both groups.

    Measured: change from baseline at 3 months postoperative.

  2. schirmer test

    schirmer test and tear breack up time test will be tested pre and postoperatively and the investigators will compare between the preoperative and postoperative results in both groups.

    Measured: change from baseline at 3 months postoperative.

  3. corneal higher order aberrations.( total RMS)

    corneal higher order aberrations( total RMS) will be measured and comparison between the preoperative and postoperative value will be conducted.

    Measured: change from baseline at 3 months postoperative.

  4. corneal resistance factor

    corneal resistance factor will be measured by ORA device and the investigators will compare between the preoperative and postoperative results in both groups.

    Measured: change from baseline at 3 months postoperative.

  5. tear break up time test.

    tear breack up time test will be tested pre and postoperatively and the investigators will compare between the preoperative and postoperative results in both groups.

    Measured: change from baseline at 3 months postoperative.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Nov 2016 (estimated)
  2. Study startMar 2015
  3. Primary completionDec 2016 (estimated)
  4. Study completionFeb 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02962544
Sponsor's protocol ID
151
Status last verified
Nov 2016
First submitted
24 Oct 2016
Last updated
11 Nov 2016
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing FS-SMILE, FS- LASIK and Visumax device in people with Myopia, run by Kasr El Aini Hospital at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Nov 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Esraa MA El-Mayah, Msc ((002)01002208106, e_mayah87@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

refractive predictability(manifest refraction spherical equivalent using autorefractometer) (time frame: change from baseline at 3 months postoperative.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Nov 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in